ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Data Presented At Scientific Meetings Can Have Impact On Patient Treatment

March 31, 2006

Stronger Federal Role Needed To Improve Palliative Care.

June 22, 2001

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007

FDA Approves BMS’s Yervoy For Metastatic Melanoma

March 25, 2011

Minorities Increasingly Involved In Research, Training Programs

December 5, 1986

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990